Abstract. DNA amplifications activate oncogenes and are hallmarks of nearly all advanced cancers including head and neck squamous cell carcinoma (HNSCC). Some oncogenes show both DNA copy number gain and mRNA overexpression. Chromosomal comparative genomic hybridization and oligonucleotide microarrays were used to examine 8 HNSCC cell lines and a plot of gene expression levels relative to their position on the chromosome was produced. Three highly up-regulated genes, NT5C3, ANLN and INHBA, were identified on chromosome 7p14. These genes were subjected to quantitative real-time RT-PCR on cDNA and genomic DNA derived from 8 HNSCC cell lines. ANLN and INHBA showed a strong positive correlation between mRNA expression and genomic DNA levels and a similar relationship was shown for the known oncogene, EGFR, at 7p11.2. In clinical samples, ANLN and INHBA showed a significantly higher expression in tumors than in normal tissues. Patients with high expression levels of INHBA had a shorter diseasefree survival rate. Therefore, INHBA may be a promising prognostic marker of HNSCC.
Introduction
Carcinomas of the head and neck represent the sixth most common cancer worldwide and at least 90% of them are squamous cell carcinomas. Despite considerable advances in surgery, radiotherapy and chemotherapy, the 5-year survival rate for HNSCC patients has improved only marginally over the past decade. Local tumor recurrence, second primary tumors and distant metastasis after conventional therapy appear to be major contributing factors for restricted survival of HNSCC patients. Local tumor recurrence affects ~60% of patients and metastases develop in 15-25% of patients (1) . Many factors, such as TNM stage, pathological grade and tumor site, influence the prognosis of HNSCC but are not sufficient to predict outcome. In addition, treatment often results in impairment of functions such as speech and swallowing, cosmetic disfiguration and mental pain. These inflictions significantly erode quality of life. To overcome this situation, there is a need to find novel biomarkers that classify patients into prognostic groups, to aid identification of highrisk patients who may benefit from different treatments.
Comparative genomic hybridization (CGH) has facilitated chromosomal characterization of solid tumors as it can provide detailed information on gains and loss of tumor DNA throughout the entire genome. CGH has been widely used to analyze many types of tumors, including HNSCC (2, 3) . The pattern of aberration, which comprises the numbers and types of aberrations and the regions that are recurrently altered, is characteristic for each tumor type. Most findings based on CGH, however, have shown only slight DNA copy number aberrations because of the large chromosomal areas detected. Also, identification of tumor-related genes is difficult because an extremely large number of genes are within these regions. In this study, gene expression analyses using DNA microarray was performed and combined with the results of CGH. Gene expression profiling has recently been used to promote rational approaches to therapy as well as to improve diagnosis and prognosis in many tumor types (4-6), including HNSCC (1) .
Cancers, including HNSCC, are characterized by a complex pattern of cytogenetic and molecular genetic changes. Several chromosomal regions are recurrently amplified or deleted in these tumors, but little is known about specific underlying genes that could be important mediators in tumor formation or progression. The relationship between change in DNA content and gene expression is unknown. Therefore, identification of affected genes in these loci, elucidation of their functions and association of these genes with cancer progression, are required to fully understand HNSCC tumorigenesis and progression.
Oncogenes can be activated by mutation, structural rearrangement or amplification and tumor suppressor genes may be inactivated in some tumors by methylation and in others by mutation or physical deletion. DNA amplification is an important and common mechanism for oncogene overexpression in many cancers. Some oncogenes have been ONCOLOGY REPORTS 18: 1489 -1497 , 2007 Identification of molecular targets in head and neck squamous cell carcinomas based on genome-wide gene expression profiling Genomic DNA extraction and chromosomal CGH. Genomic DNA was extracted using the blood and cell culture DNA kit (Qiagen, Valencia, CA) according to the manufacturer's procedures. CGH was performed as described previously (8) . DNA from each cell line was directly labeled with Spectrum Green-dUTP (Vysis Inc., Downers Grove, IL) by nick translation using a commercial kit (Vysis). Normal, sex-matched reference DNA was labeled with SpectrumRed-dUTP (Vysis). Labeled cell line and reference DNAs, together with human Cot-1 DNA, were denatured and hybridized to metaphase spreads that were prepared using a standard protocol. The slides were washed and counterstained with DAPI. Threshold values for detection of genomic imbalances were determined as 0.7 for loss and 1.3 for gains.
Oligonucleotide microarray experiment. Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA) following the manufacturer's procedures. Total RNA quality was checked by the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). The AceGene ® Human Oligo Chip 30K (Hitachi Software Engineering Co. Ltd., Yokohama, Japan) was used for expression profiling. A total of 30,336 spots corresponding to 29,640 independent genes are contained in this array. Oligonucleotide microarray analysis was performed on 8 HNSCC cell lines. aRNA was prepared with the Amino Allyl MessageAmp aRNA kit (Ambion, Austin, TX). Each aRNA from 8 cell lines was labeled with Cyanine 5, whereas aRNA from Universal Reference Total RNA (Clontech, Mountain View, CA) was labeled with Cyanine 3 as a control. The outline of a protocol is available on the web site (http://www.dna-chip.co.jp/thesis/AceGeneProtocol.pdf). Probe purification, hybridization, and washings were performed according to the manufacturer's instructions. Microarray slides were scanned using the Packard GSI Lumonics scanArray 4000 (Perkin Elmer, Boston, MA). Data were analyzed by DNASISarray software (Hitachi Software Engineering Co. Ltd.), which converted the signal intensity of each spot into text format. Log2-ratios of median local background subtracted intensity levels were analyzed. Each microarray data was normalized by Lowess normalization. Reactions were performed with the same conditions as above. Human female genomic DNA (Novagen, Madison, WI) was used as a normal control. Experiments were performed in duplicate. DNA levels were normalized to SUFU (10q24) DNA levels, which were designed within a region of euploid copy number as shown by CGH analysis.
Statistical analysis. Microarray expression data and CGH results were combined by arranging gene expression levels on each chromosome. Map positions of the genes were obtained from the NCBI database (http://www.ncbi.nlm. nih.gov/genome/guide/human/). Spearman's rank correlation coefficient (r s ) was used to measure and to test the correlation between two random variables. Relative expression levels obtained by quantitative real-time RT-PCR were subjected to the Mann-Whitney U test to identify differences in gene expression levels between 2 groups. Sample clusters were compared to clinicopathological data of patients using Fisher's exact test. The Kaplan-Meier method was used to plot diseasefree survival and the log-rank test was used to compare curves. Statistical significance was defined as P-value of <0.05.
Results
Chromosomal CGH performed on 8 HNSCC cell lines. All cell lines had some chromosomal alterations detected by CGH and many of the copy number alterations were common to most cell lines (Fig. 1) . The most frequent chromosomal copy number gains were observed on chromosome arms 5p (7/8 cell lines), 7p (7p22: 7/8; 7p21-p15: 5/8; 7p14-p11. was 107 genes in 5p, 219 genes in 7p and 310 genes in 20q. More detailed data of these regions are shown in Table I . The cutoff value of microarray expression levels was set at 2-fold and 81 genes were up-regulated >2-fold in these regions: 21 genes in 5p, 39 genes in 7p and 21 genes in 20q (Table II) . These up-regulated genes located with high number (10 genes) at 5p13, 7p15 and 7p14 and located with high probability at 7p14 (10/33) and 7p11.2 (6/13). Average expression levels of the regions were 1.834-fold at 5p13, 1.824-fold at 7p14 and 2.185-fold at 7p11.2. These values were significantly higher than the average of all genes, which was 1.162-fold. These results did not seem to be related to the length of chromosomal region or the percentage of genes located on the chromosome. From these analyses, 5p13, 7p14 and 7p11.2 were likely candidate chromosomal regions. Among these three regions, we focused on 7p14, which is a novel chromosomal gain region of HNSCC.
Candidate genes within 7p14. Gene expression values, relative to their position along the chromosome, were plotted. Fig. 2A shows the gene expression values of chromosome arm 7p obtained from microarray analysis of 8 HNSCC cell lines and the average gene expression values. Although not all genes in 7p14 had the same tendency to be up-regulated, and there were both up-and down-regulated genes in each region, the average expression values of the genes contained in 7p14 (also in 7p11.2) was significantly higher than other 7p regions (P<0.01; Table I ).
The 33 genes that were altered on the microarray were contained in 7p14 (Fig. 2B ) and among these, the 3 most upregulated genes (NT5C3, ANLN and INHBA) and EGFR were subjected to quantitative real-time RT-PCR. EGFR (epidermal growth factor receptor) is overexpressed in several epithelial malignancies, including HNSCC. The EGFR gene plays a critical role in HNSCC growth, invasion, metastasis and angiogenesis so this gene was used as a comparison.
Quantitative real-time RT-PCR verification of cell lines. mRNA expression levels of the cell lines were compared with Human Universal Reference Total RNA, while genomic DNA expression levels of the cell lines were compared with human female genomic DNA (Fig. 3) . Among the 3 up-regulated genes, ANLN and INHBA showed strong positive correlation of mRNA expression levels and genomic DNA expression levels in each cell line (ANLN: r s =0.786, P=0.038; INHBA: r s =0.857, P=0.023). A strong correlation for EGFR was also found (r s =0.905, P=0.017).
Quantitative real-time RT-PCR using clinical samples. Next, mRNA expression levels of the 3 up-regulated genes and EGFR in normal squamous epithelial tissues and HNSCC specimens of patients were compared (Fig. 4) . Quantitative real-time RT-PCR of 18 normal tissues and 22 tumors demonstrated that ANLN and INHBA were significantly overexpressed in tumors compared to normal tissues (P<0.001). There was also a statistically significant overexpression of EGFR in tumors. Furthermore, when 18 tumors were compared to paired normal tissues, both ANLN and INHBA expression levels were higher in each of the tumor samples. The average tumor/normal tissue ratios were 5.5 and 28.6, respectively. Table I . Gene expression profiles of chromosome arms 5p, 7p and 20q. - Table II . Up-regulated genes >2-fold in 5p, 7p and 20q.
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No. Symbol Gene name Accession Location Fold in array Gene function Table II . Continued. 20q in 8 HNSCC cell lines. Many regions of copy number alterations matched the regions described in the published literature for HNSCC (2, 3) and are also characteristic of other squamous cell carcinomas, such as esophagus, cervix and anal tumors (9) . In HNSCC, DNA copy number gains were frequently observed on these chromosome arms as well as the most common gain regions, 3q and 11q13. In this study, 3q26-29 and 11q12-14 were also involved in chromosomal gain regions in >50% of the 8 cell lines. For HNSCC, there are studies that a gain of 5p14 was associated with short-term survival after surgery (10) . In addition, the average diseasefree survival of OSCC without 7p copy number gain clearly exceeded that of tumors with a gain at 7p (11) . No such relationship has been found for 20q. On chromosome arms 5p, 7p and 20q, 81 genes were identified that were up-regulated >2-fold by microarray analysis. When these microarray results were classified according to their function, 21 of 81 genes were known genes with no functional annotation. Of the remaining 60 genes, 52% (31/60) were involved in metabolism, 13% (8/60) in transport, 12% (7/60) in cell cycle, 5% (3/60) in apoptosis and cell proliferation and 3% (2/60) in cell growth and signal transduction. These functions are essential for normal cellular processes but may be also implicated in development and progression of HNSCC. There are reports that about half of these 81 genes are related to malignant tumors and at least 15 genes are related specifically to squamous cell carcinomas. This gene list will aid in the search for new HNSCC-related genes.
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Quantitative real-time RT-PCR on 3 of the up-regulated genes (NT5C3, ANLN and INHBA) contained in 7p14 was performed. ANLN and INHBA relative gene copy numbers were significantly correlated with mRNA expression levels, a finding similar to EGFR, a gene known to be overexpressed in epithelial malignancies. Also, in the analysis using clinical samples, mRNA expression levels of these two genes were significantly higher in all 18 tumors than matched normal tissues. Furthermore, expression levels of ANLN and INHBA Table III . Correlation between ANLN and INHBA expression and clinicopathological characteristics.
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ANLN expression INHBA expression -----------------P-value a -----------------P-value a Low High Low High All cases  27  22  30  19 
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